(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. PKA inhibits the wave of neurogenesis in the zebrafish retina. (A-C) In
situ hybridisation of embryos at 25 (A), 27 (B) and 31 (C) hpf with an
ath5 RNA probe. ath5 mRNA expression is initiated at the
ventronasal retina (A, arrowhead) and progresses to the central region of the
neural retina (B, arrowheads). (D,E) ath5 expression in the 33-hpf
retina treated with forskolin (E) or with DMSO as a control (D). In the
forskolin-treated retina, ath5 expression is initiated normally in a
few cells adjacent to the optic stalk tissue (E, arrowhead), but does not
spread to the dorsal and temporal retina. (F) ath5 expression in the
33-hpf forskolin-treated embryo in which dnPKA is overexpressed.
Overexpression of dnPKA rescues ath5 expression. Note that
ath5 expression is observed in isolated cells in the dorsotemporal
retina (arrowheads), suggesting cell-autonomous rescue of ath5
expression. (G,H) ath5:GFP expression in 48-hpf cyclopamine-treated (H) and
control (G) retinas. The progression of ath5:GFP expression is mildly delayed
in the presence of cyclopamine. (I-L) In situ hybridisation of
forskolin-treated and control retinas with islet1 (I,J) and
lim3 RNA probes (K,L). Lateral view of optic cups at 48 (I,J) and 33
(K,L) hpf. Both islet1 and lim3 are expressed in a few cells
adjacent to the optic stalk (arrowheads), but their expression does not
progress in the presence of forskolin (J,L). nr, nasal retina; dr, dorsal
retina; tr, temporal retina.